M&T Bank
AXSM icon

M&T Bank’s Axsome Therapeutics AXSM Stock Holding History

M&T Bank’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$414K Sell
2,447
-113
-4% -$19.5K ﹤0.01% 1207
2025
Q4 		$467K Buy
2,560
+696
+37% +$97.2K ﹤0.01% 1166
2025
Q3 		$226K Buy
+1,864
New +$210K ﹤0.01% 1337

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

M&T Bank's AXSM Position: Q1 2026 in Review

M&T Bank reduced its Axsome Therapeutics (AXSM) stake by 4.4% in Q1 2026, selling an estimated $19.5K and leaving 2,447 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #1207.

M&T Bank first reported a position in AXSM in Q3 2025 and has held it in 3 quarters since. The position peaked at $467K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • M&T Bank held 2,447 shares of Axsome Therapeutics worth $414K as of Q1 2026.
  • M&T Bank sold 113 Axsome Therapeutics shares in Q1 2026, an estimated $19.5K.
  • Axsome Therapeutics made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1207 holding.
  • M&T Bank first reported a position in Axsome Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • M&T Bank's Axsome Therapeutics position peaked at $467K in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.